Related articles:

Ironwood Pharmaceuticals Inc.: Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2016 Investor Update
February 21, 2017
February 21, 2017

Ironwood Pharmaceuticals Inc.: Ironwood Pharmaceuticals to Host Fourth Quarter and Full-Year 2016 Investor Update Call
February 07, 2017
February 7, 2017

Ironwood Pharmaceuticals Inc.: Ironwood Pharmaceuticals Provides Second Quarter 2016 Investor Update
August 04, 2016
August 4, 2016

Ironwood Pharmaceuticals Inc.: Ironwood Pharmaceuticals Provides First Quarter 2016 Investor Update
May 09, 2016
May 9, 2016

Ironwood Pharmaceuticals Inc.: Ironwood Pharmaceuticals Enters into U.S. Licensing Agreement with AstraZeneca for Lesinurad
April 26, 2016
April 26, 2016

Ironwood Pharmaceuticals Inc.: Ironwood Pharmaceuticals to Host First Quarter 2016 Investor Update Call
April 25, 2016
April 25, 2016

Ironwood Pharmaceuticals Inc.: Ironwood Pharmaceuticals Appoints Andrew Dreyfus to Board of Directors
April 07, 2016
April 7, 2016

Ironwood Pharmaceuticals Inc.: Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2015 Investor Update
February 18, 2016
February 18, 2016

Ironwood Pharmaceuticals Inc.: Ironwood Pharmaceuticals to Host Fourth Quarter and Full-Year 2015 Investor Update Call
February 04, 2016
February 4, 2016

Ironwood Pharmaceuticals Inc.: Ironwood Pharmaceuticals Provides Third Quarter 2015 Investor Update
November 03, 2015
November 3, 2015

Ironwood Pharmaceuticals Inc.: Ironwood Pharmaceuticals Provides Second Quarter 2015 Investor Update
August 05, 2015
August 5, 2015

Ironwood Pharmaceuticals Inc.: Ironwood and Allergan Enter Agreement to Co-Promote VIBERZI for Irritable Bowel Syndrome with Diarrhea (IBS-D) in the U.S.
August 05, 2015

Ironwood Pharmaceuticals Inc.: Ironwood Pharmaceuticals to Host Second Quarter 2015 Investor Update Call
July 15, 2015
July 15, 2015

Ironwood Pharmaceuticals Inc.: Ironwood Pharmaceuticals Provides First Quarter 2015 Investor Update
May 05, 2015
May 5, 2015

Ironwood Pharmaceuticals Inc.: Ironwood Pharmaceuticals Appoints Lawrence Olanoff, M.D., Ph.D., to Board of Directors
April 16, 2015
April 16, 2015

Ironwood Pharmaceuticals Inc.: Ironwood Pharmaceuticals to Host First Quarter 2015 Investor Update Call
April 15, 2015
April 15, 2015

Ironwood Pharmaceuticals Inc.: Exact Sciences and Ironwood Pharmaceuticals Enter Co-Promotion Agreement for CologuardĀ®
March 09, 2015
March 9, 2015

Ironwood Pharmaceuticals Inc.: Ironwood Pharmaceuticals Provides Fourth Quarter 2014 Investor Update
February 12, 2015
February 12, 2015

Ironwood Pharmaceuticals Inc.: Ironwood Pharmaceuticals to Host Fourth Quarter 2014 Investor Update Call
January 29, 2015
January 29, 2015

Ironwood Pharmaceuticals Inc.: Ironwood Pharmaceuticals Provides Third Quarter 2014 Investor Update
November 04, 2014
November 4, 2014

Ironwood Pharmaceuticals Inc.: Ironwood Pharmaceuticals to Host Third Quarter 2014 Investor Update Call
October 14, 2014
October 14, 2014

Ironwood Pharmaceuticals Inc.: Ironwood Pharmaceuticals Provides Second Quarter 2014 Investor Update
August 04, 2014
August 4, 2014

Ironwood Pharmaceuticals Inc.: Ironwood Pharmaceuticals to Host Second Quarter 2014 Investor Update Call
July 07, 2014
July 7, 2014

Ironwood Pharmaceuticals Inc.: Ironwood Pharmaceuticals Appoints Douglas Williams, Ph.D., to Board of Directors
June 04, 2014
June 4, 2014

Ironwood Pharmaceuticals Inc.: Ironwood Pharmaceuticals Provides First Quarter 2014 Investor Update
April 29, 2014
April 29, 2014

Ironwood Pharmaceuticals Inc.: Ironwood Pharmaceuticals to Host First Quarter 2014 Investor Update Call
April 08, 2014
April 8, 2014

Pin It on Pinterest

Share This